Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Phillips 66, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Adient plc March 10, 202698.2%
-
Bio-Techne Corp October 30, 202596.8%
-
Adient plc March 11, 202598.8%
-
Bio-Techne Corp October 25, 202496.4%
-
Phillips 66 May 15, 202491.7%
-
Adient plc March 12, 202499.5%
-
Bio-Techne Corp October 26, 202393.2%
-
Adient plc March 7, 202398.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 29, 2026 | Bio-Techne Corp | Grant or award | +2,750 | — | — |
| Mar 10, 2026 | Adient plc | Grant or award | +8,208 | — | — |
| Jan 15, 2026 | Phillips 66 | Grant or award | +1,423 | $140.56 | $200,017 |
| Oct 30, 2025 | Bio-Techne Corp | Grant or award | +1,640 | — | — |
| Mar 11, 2025 | Adient plc | Grant or award | +10,118 | — | — |
| Jan 15, 2025 | Phillips 66 | Grant or award | +1,684 | $118.78 | $200,026 |
| Oct 24, 2024 | Bio-Techne Corp | Grant or award | +1,462 | — | — |
| Mar 12, 2024 | Adient plc | Grant or award | +4,207 | — | — |
| Jan 16, 2024 | Phillips 66 | Grant or award | +1,524 | $131.31 | $200,116 |
| Oct 26, 2023 | Bio-Techne Corp | Grant or award | +1,625 | — | — |
| Mar 7, 2023 | Adient plc | Grant or award | +3,312 | — | — |
| Jan 17, 2023 | Phillips 66 | Grant or award | +1,929 | $103.69 | $200,018 |
Questions about Julie L. Bushman
What boards is Julie L. Bushman on?
Julie L. Bushman sits on the boards of Adient plc, Bio-Techne Corp and Phillips 66.
How long has Julie L. Bushman served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.